BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35720004)

  • 1. Application of Imaging Indicators Based on
    Sun CF; Zhang D; Gao Y; Mao XY; Tan ZH; Bao SL; Shen C
    Front Oncol; 2022; 12():888680. PubMed ID: 35720004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution Characteristics of Colorectal Peritoneal Carcinomatosis Based on the Positron Emission Tomography/Peritoneal Cancer Index.
    Sun CF; Tan ZH; Shen C; Mao XY; Ge CC; Gao Y; Hu CH
    Cancer Biother Radiopharm; 2022 Sep; 37(7):517-526. PubMed ID: 32833546
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Su W; Zhao S; Chen Y; Zuo C; Cui B; Wang M; Ren F
    Abdom Radiol (NY); 2020 Mar; 45(3):743-749. PubMed ID: 31907569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Correlation Between
    Zhang LF; Li JL; Wang YH; Tai XH; Liu L; Zhang XX; An YW; Li HL
    Cancer Biother Radiopharm; 2023 Aug; 38(6):364-370. PubMed ID: 34529925
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of [
    Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of
    Yin YX; Xie MZ; Liang XQ; Ye ML; Li JL; Hu BL
    Front Oncol; 2021; 11():741612. PubMed ID: 34956868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head comparison of [
    Kuten J; Levine C; Shamni O; Pelles S; Wolf I; Lahat G; Mishani E; Even-Sapir E
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):743-750. PubMed ID: 34302504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/computed Tomography in the Follow-up of Colorectal Cancer: Searching off Approaches Increasing Specificity for Detection of Recurrence.
    Ince S; Okuyucu K; Hancerliogulları O; Alagoz E; San H; Arslan N
    Radiol Oncol; 2017 Dec; 51(4):378-385. PubMed ID: 29333115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of ¹⁸F-FDG PET-CT maximum standard uptake value and T/N ratio with the prognosis of postoperative colorectal cancer].
    Wang X; Peng G; Zhang X; Chen Z; Zhang B; Li Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Mar; 18(3):232-7. PubMed ID: 25809325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
    Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
    Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between HER2 expression and
    Ozen A; Tatar G
    Hell J Nucl Med; 2022; 25(1):5-10. PubMed ID: 35388798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Liberale G; Lecocq C; Garcia C; Muylle K; Covas A; Deleporte A; Hendlisz A; Bouazza F; El Nakadi I; Flamen P
    Anticancer Res; 2017 Feb; 37(2):929-934. PubMed ID: 28179354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can [
    Elekonawo FMK; Starremans B; Laurens ST; Bremers AJA; de Wilt JHW; Heijmen L; de Geus-Oei LF
    Abdom Radiol (NY); 2020 Feb; 45(2):301-306. PubMed ID: 31642963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation among maximum standardized
    Zhang Y; Li B; He Y; Pang L; Yu H; Shi H
    Hell J Nucl Med; 2022; 25(1):38-42. PubMed ID: 35388803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis.
    Suzuki A; Kawano T; Takahashi N; Lee J; Nakagami Y; Miyagi E; Hirahara F; Togo S; Shimada H; Inoue T
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1413-20. PubMed ID: 15205922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.
    Cho SH; Kim SW; Kim WC; Park JM; Yoo IeR; Kim SH; Oh ST
    World J Gastroenterol; 2013 Jun; 19(22):3453-8. PubMed ID: 23801838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.